239 related articles for article (PubMed ID: 25680585)
1. Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.
Farsani ZS; Behmanesh M; Sahraian MA
J Neurol Sci; 2015 Mar; 350(1-2):18-23. PubMed ID: 25680585
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D supplementation up-regulates IL-6 and IL-17A gene expression in multiple sclerosis patients.
Naghavi Gargari B; Behmanesh M; Shirvani Farsani Z; Pahlevan Kakhki M; Azimi AR
Int Immunopharmacol; 2015 Sep; 28(1):414-9. PubMed ID: 26188623
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta.
Åivo J; Hänninen A; Ilonen J; Soilu-Hänninen M
J Neuroimmunol; 2015 Mar; 280():12-5. PubMed ID: 25773149
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D levels in multiple sclerosis patients: Association with TGF-β2, TGF-βRI, and TGF-βRII expression.
Shirvani-Farsani Z; Behmanesh M; Mohammadi SM; Naser Moghadasi A
Life Sci; 2015 Aug; 134():63-7. PubMed ID: 26037400
[TBL] [Abstract][Full Text] [Related]
5. The impact of vitamin D3 intake on inflammatory markers in multiple sclerosis patients and their first-degree relatives.
Hashemi R; Hosseini-Asl SS; Arefhosseini SR; Morshedi M
PLoS One; 2020; 15(4):e0231145. PubMed ID: 32251441
[TBL] [Abstract][Full Text] [Related]
6. Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial.
Ashtari F; Toghianifar N; Zarkesh-Esfahani SH; Mansourian M
Neuroimmunomodulation; 2015; 22(6):400-4. PubMed ID: 26401986
[TBL] [Abstract][Full Text] [Related]
7. The rs3761548 FOXP3 variant is associated with multiple sclerosis and transforming growth factor β1 levels in female patients.
Flauzino T; Alfieri DF; de Carvalho Jennings Pereira WL; Oliveira SR; Kallaur AP; Lozovoy MAB; Kaimen-Maciel DR; de Oliveira KB; Simão ANC; Reiche EMV
Inflamm Res; 2019 Nov; 68(11):933-943. PubMed ID: 31414141
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of vitamin D3 in multiple sclerosis patients.
Mosayebi G; Ghazavi A; Ghasami K; Jand Y; Kokhaei P
Immunol Invest; 2011; 40(6):627-39. PubMed ID: 21542721
[TBL] [Abstract][Full Text] [Related]
9. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation.
Mahon BD; Gordon SA; Cruz J; Cosman F; Cantorna MT
J Neuroimmunol; 2003 Jan; 134(1-2):128-32. PubMed ID: 12507780
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D treatment in multiple sclerosis.
Myhr KM
J Neurol Sci; 2009 Nov; 286(1-2):104-8. PubMed ID: 19549608
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and autoimmune disease--implications for practice from the multiple sclerosis literature.
Mark BL; Carson JA
J Am Diet Assoc; 2006 Mar; 106(3):418-24. PubMed ID: 16503232
[TBL] [Abstract][Full Text] [Related]
13. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?
Razmkhah M; Jaberipour M; Erfani N; Habibagahi M; Talei AR; Ghaderi A
Cell Immunol; 2011; 266(2):116-22. PubMed ID: 20970781
[TBL] [Abstract][Full Text] [Related]
14. The presence of GM-CSF and IL-4 interferes with effect of TGF-beta1 on antigen presenting cells in patients with multiple sclerosis and in rats with experimental autoimmune encephalomyelitis.
Xiao BG; Zhu WH; Lu CZ
Cell Immunol; 2007 Sep; 249(1):30-6. PubMed ID: 18061154
[TBL] [Abstract][Full Text] [Related]
15. Effect of adjunctive roxithromycin therapy on interleukin-1β, transforming growth factor-β1 and vascular endothelial growth factor in gingival crevicular fluid of cyclosporine A-treated patients with gingival overgrowth.
Gong Y; Lu J; Ding X; Yu Y
J Periodontal Res; 2014 Aug; 49(4):448-57. PubMed ID: 23947915
[TBL] [Abstract][Full Text] [Related]
16. The effect of vitamin D on expression of TGF β1 in ovary.
Corduk N; Abban G; Yildirim B; Sarioglu-Buke A
Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):490-3. PubMed ID: 22851187
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of interleukin (IL)-10, IL-17, transforming growth factor (TGF)-β1, and interferon-γ cytokines and expression levels of IL-10 and TGF-β1 genes in renal allograft recipients after donor bone marrow cell infusion.
Mohammadnia M; Solgi G; Ranjbar M; Shahrestani T; Edalat R; Razavi A; Nikbin B; Pourmand G; Amirzargar M; Sarafnejad A; Amirzargar AA
Transplant Proc; 2011 Mar; 43(2):495-9. PubMed ID: 21440743
[TBL] [Abstract][Full Text] [Related]
18. Cotransfection with IL-10 and TGF-β1 into immature dendritic cells enhances immune tolerance in a rat liver transplantation model.
Chen L; Zheng L; He W; Qiu M; Gao L; Liu J; Huang A
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G575-81. PubMed ID: 24503768
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Thouvenot E; Orsini M; Daures JP; Camu W
Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
[TBL] [Abstract][Full Text] [Related]
20. Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion.
Zhao SQ; Li J; Liu H; Zhang QG; Wang Y; Han DM
Chin Med J (Engl); 2009 Sep; 122(18):2149-54. PubMed ID: 19781301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
